文献速递细菌感染、耐药与抗菌药物医院感染防控

英国抗菌化疗学会二十年耐药监测项目的设计与启示

Two decades of resistance surveillance by the British Society for Antimicrobial Chemotherapy: design, development, delivery, deficiencies and future directions.
PubMed 文献 · J Antimicrob Chemother · 2025-01-01

英国抗菌化疗学会抗菌药物监测项目于1999至2019年在英国和爱尔兰开展,采用医学慈善机构、制药企业与检测实验室合作的新模式,收集社区和医院获得性呼吸道及血流感染分离株。项目期间对近10万株、17个菌属、44种抗菌药物产生检测结果并每年通过专门网站公布,但2010年后支持下降,20年后停止采集,细菌库保留供未来使用。

要点

  • 该项目采用慈善机构、药企与实验室三方合作模式,覆盖社区与医院感染分离株。
  • 1999至2019年累计检测近10万株、17个菌属、44种抗菌药物,结果每年在线公布。
  • 2010年后支持下降导致20年后停止采集,但细菌库保留供未来抗菌药物耐药研究。

核心结论

  • 该项目在20年间提供了近10万株细菌对44种抗菌药物的检测结果,但2010年后支持下降导致采集停止。

研究设计与样本

  • 项目为医学慈善机构、制药企业与签约检测实验室合作的整合性监测项目,下设分别针对社区和医院获得性呼吸道及血流感染分离株的独立Programme。
  • 1999至2019年间累计检测近10万株分离株,覆盖17个细菌属和44种抗菌药物。

主要发现

  • 项目结果每年通过专门构建的网站公布。
  • 与公共部门机构合作使项目数据可与英国国家医疗服务体系实验室常规收集数据进行比较。
  • 2010年后项目支持下降,采集在20年后停止,停止与合作伙伴组织优先级变化有关。

临床怎么用

  • 该项目的合作模式与年度在线公布结果的方式可为抗菌药物耐药监测体系设计提供参考。
  • 项目保留的细菌库可用于未来抗菌药物耐药相关研究。

局限性

  • 2010年后支持下降导致项目采集在20年后停止。
  • 项目停止与合作伙伴组织优先级变化有关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The British Society for Antimicrobial Chemotherapy Antimicrobial Surveillance Project was established in the United Kingdom (UK) and Ireland in response to dissatisfaction with existing antimicrobial surveillance which, in the 1990s, was fragmented and poorly informative for clinical and public heath purposes. The model developed into an integrated Project that was novel in its management and financing, being a true collaboration between a medical charity, pharmaceutical companies and the laboratories contracted to perform the testing. Separate 'Programmes' within an overall 'Project' collected and tested community- and hospital-acquired respiratory and bloodstream infection isolates. Cooperation with public sector bodies allowed data collection from the Project to be compared to routinely collected data from National Health Service laboratories. Between 1999 and 2019 the Project delivered test results on almost 100 000 isolates, from 17 bacterial genera to 44 antimicrobial agents. The results were made available annually on a specially constructed web site. In this supplement, we summarize the data collected in a series of papers relevant to the two programmes, discussing the Project's strengths and deficiencies. Support for the Project declined in the period after 2010, and collection ceased after 20 years, its demise related to changing priorities within the partner organizations. However, the bacterial collection remains and is to be maintained to assist in future work in combating antimicrobial resistance.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. MacGowan AP, Reynolds R, Parcell BJ, et al. Two decades of resistance surveillance by the British Society for Antimicrobial Chemotherapy: design, development, delivery, deficiencies and future directions. J Antimicrob Chemother. 2025. PMID: 41140270. doi:10.1093/jac/dkaf247

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。